Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790MKenneth S. Thress, Geoffrey R. Oxnard, Cloud P. Paweletz et al.|Nature Medicine|2015Cited by 1.5k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNAM.C. Liu, David R. Spigel, Neil Fleshner et al.|Annals of Oncology|2020Cited by 1.5k
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewJason D. Merker, Nicholas C. Turner, Geoffrey R. Oxnard et al.|Journal of Clinical Oncology|2018Cited by 925
Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung CancerGeoffrey R. Oxnard, Pasi A. Jänne, Kenneth S. Thress et al.|Journal of Clinical Oncology|2016Cited by 843
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung CancerAlexander Drilon, Vivek Subbiah, Geoffrey R. Oxnard et al.|New England Journal of Medicine|2020Cited by 835